Mindray C1A Automated External Defibrillator (AED) Fully Automated

Suitable for use on Adults & Children

Designed for both professional first responders and bystanders, this state-of-the-art Mindray defibrillator combines cutting-edge technology with user-friendly features to ensure rapid response in critical situations.

Dimensions: 210 mm (w) x 286 mm (d) x 78 mm (h)
Weight: 2.0 kg including battery
Download Specification Sheet Here

What’s Included?

Mindray BeneHeart C1A Defibrillator, Fully Automated
Soft case with handle and pouch
5-year battery
5-year electrode kit (pads)
Green, plastic AED sign (A4)
Premium prep-kit (shears, dry towel, razor, gloves, bio-hazard bag and CPR mask)
AED test tag
8-year warranty

Sudden cardiac arrest (SCA) is one of the leading causes of death worldwide, claiming a life every five seconds. Even more alarming, 90% of these incidents occur outside of medical institutions — in public spaces, workplaces, or homes — often leaving bystanders with little time and no training to intervene. This critical delay in response can drastically reduce survival rates, making early defibrillation essential to saving lives.

The Mindray BeneHeart C1A AED is designed to address this challenge head-on. Engineered for ease of use and fast action, the C1A empowers bystanders and first-time responders to deliver life-saving aid confidently and effectively. Whether in the semi-automatic or fully automatic version, the C1A makes high-performance defibrillation more accessible than ever. With integrated smart guidance systems and powerful shock delivery, it gives anyone the ability to act decisively in the moments that matter most.

Life-Saving Technology Overview

The BeneHeart C1A incorporates three groundbreaking technologies that revolutionise public-access defibrillation. The ResQNavi™ Technology provides intelligent step-by-step guidance, adapting to the rescuer’s actions and pace. Through clear voice prompts and animations, it coaches users through the entire resuscitation process, offering appropriate encouragement and direction based on response times.

At the heart of the C1A is the QShock™ Technology, which delivers the first shock in under 8 seconds from analysis start. This rapid response is achieved through simultaneous ECG analysis and capacitor pre-charging, eliminating precious seconds from the traditional charging sequence. In cardiac arrest, where every second counts, this acceleration can significantly improve survival chances.

The device features advanced 360J Biphasic Truncated Exponential (BTe) technology, aligning with the latest Australian Resuscitation Council guidelines. This higher energy capability for subsequent shocks has proven particularly effective in terminating persistent arrhythmias, especially in cases where lower energy levels prove insufficient.